HDAC9 and acute myeloid leukemia: In conclusion, our findings show that I3, an HDAC inhibitor and a chromatin-remodeling agent, has significant anti-proliferative effects on AML cells with t (8; 21) translocation or MLLr by inducing cell differentiation.